{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:26:27Z","timestamp":1783445187496,"version":"3.54.6"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.annpat.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:33:31Z","timestamp":1771274011000},"page":"301-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Les particularit\u00e9s cliniques, histopathologiques et biologiques des carcinomes lobulaires infiltrants"],"prefix":"10.1016","volume":"46","author":[{"given":"Lounes","family":"Djerroudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigleta","family":"Brahimaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad El","family":"Sabeh-Ayoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Salesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Bendali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Cernat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoire","family":"Montecalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kondratowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fresia","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2026.01.006_bib0415","year":"2019"},{"key":"10.1016\/j.annpat.2026.01.006_bib0420","first-page":"491","article-title":"Lobular carcinoma in situ: a rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0425","series-title":"Les tumeurs du sein","author":"Cornil","year":"1908"},{"key":"10.1016\/j.annpat.2026.01.006_bib0430","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-020-01384-6","article-title":"Invasive lobular carcinoma of the breast: the increasing importance of this special subtype","volume":"23","author":"McCart Reed","year":"2021","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0435","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/jnci\/djac157","article-title":"Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer","volume":"114","author":"Oesterreich","year":"2022","journal-title":"JNCI"},{"key":"10.1016\/j.annpat.2026.01.006_bib0440","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","article-title":"Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15\u00a0International Breast Cancer Study Goup clinical trials","volume":"26","author":"Pestalozzi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0445","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2007.10.009","article-title":"Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes","volume":"44","author":"Rakha","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0450","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.3390\/cancers13153695","article-title":"Lobular breast cancer: histomorphology and different concepts of a special spectrum of tumors","volume":"13","author":"Christgen","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2026.01.006_bib0455","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1002\/cncr.33104","article-title":"Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer","volume":"126","author":"Christgen","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0460","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0959-8049(20)30542-6","article-title":"Clinical utility of MammaPrint testing in invasive lobular carcinoma: results from the MINDACT phase III trial","volume":"138","author":"Metzger","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0465","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41379-022-01135-2","article-title":"Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer","volume":"35","author":"De Schepper","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0470","doi-asserted-by":"crossref","first-page":"100497","DOI":"10.1016\/j.modpat.2024.100497","article-title":"Integration of pathological criteria and immunohistochemical evaluation for invasive lobular carcinoma diagnosis: recommendations from the European Lobular Breast Cancer Consortium","volume":"37","author":"De Schepper","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2022.05.006","article-title":"Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer","author":"Van Baelen","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0480","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.21.00640","article-title":"Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast","volume":"39","author":"Yadav","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.annpat.2026.01.006_bib0485","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.14829","article-title":"Update on lobular lesions of the breast","volume":"82","author":"Kuba","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2026.01.006_bib0490","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cjp2.76","article-title":"Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma","volume":"3","author":"Christgen","year":"2017","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0495","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000442884","article-title":"Invasive lobular carcinoma mimicking papillary carcinoma: a report of three cases","volume":"83","author":"Rakha","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.annpat.2026.01.006_bib0500","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cjp2.253","article-title":"Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma","volume":"8","author":"Christgen","year":"2022","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0505","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41379-022-01084-w","article-title":"Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity","volume":"35","author":"Soong","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0510","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/modpathol.2012.197","article-title":"Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?","volume":"26","author":"Rakha","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0515","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1038\/s41379-020-0591-3","article-title":"E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements","volume":"33","author":"Christgen","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0520","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/path.5040","article-title":"Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology","volume":"244","author":"McCart Reed","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0525","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-008-0007-4","article-title":"The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology","volume":"114","author":"Rakha","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.annpat.2026.01.006_bib0530","doi-asserted-by":"crossref","first-page":"100463","DOI":"10.1016\/j.modpat.2024.100463","article-title":"Molecular and clinical portrait of HER2-low invasive lobular carcinomas","volume":"37","author":"Djerroudi","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0535","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/his.12869","article-title":"E-cadherin immunohistochemistry in breast pathology: uses and pitfalls","volume":"68","author":"Canas-Marques","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2026.01.006_bib0540","doi-asserted-by":"crossref","first-page":"100570","DOI":"10.1016\/j.modpat.2024.100570","article-title":"E-Cadherin mutational landscape and outcomes in breast invasive lobular carcinoma","volume":"37","author":"Djerroudi","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0545","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41379-019-0209-9","article-title":"The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts","volume":"32","author":"Alsaleem","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0550","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2005.02156.x","article-title":"E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance","volume":"46","author":"Rakha","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2026.01.006_bib0555","doi-asserted-by":"crossref","first-page":"100837","DOI":"10.1016\/j.modpat.2025.100837","article-title":"Pitfalls in the histological diagnosis of morphologic variants of invasive lobular carcinoma of the breast","volume":"38","author":"Floris","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0560","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.ejca.2010.05.013","article-title":"Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma","volume":"46","author":"Gruel","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0565","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.annpat.2026.01.006_bib0570","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1200\/JCO.2015.64.0334","article-title":"Genomic characterization of primary invasive lobular breast cancer","volume":"34","author":"Desmedt","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0575","doi-asserted-by":"crossref","first-page":"18517","DOI":"10.1038\/srep18517","article-title":"Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer","volume":"6","author":"Michaut","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.annpat.2026.01.006_bib0580","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/cancers13081950","article-title":"The genomic landscape of lobular breast cancer","volume":"13","author":"McCart Reed","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2026.01.006_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-024-00508-x","article-title":"Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1\u00a0genetic alterations","volume":"8","author":"Dopeso","year":"2024","journal-title":"NPJ Precis Onc"},{"issue":"20","key":"10.1016\/j.annpat.2026.01.006_bib0590","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1158\/0008-5472.CAN-24-1322","article-title":"A genomics-driven artificial intelligence-based model classifies breast invasive lobular carcinoma and discovers CDH1 inactivating mechanisms","volume":"84","author":"Pareja","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0595","doi-asserted-by":"crossref","first-page":"73337","DOI":"10.18632\/oncotarget.11819","article-title":"ERBB2\u00a0mutations associated with solid variant of high-grade invasive lobular breast carcinomas","volume":"7","author":"Deniziaut","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.annpat.2026.01.006_bib0600","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djac157","article-title":"Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer","author":"Oesterreich","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annpat.2026.01.006_bib0605","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8","article-title":"Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975\u00a0cases with reference to data on conservative therapy and metastatic patterns","volume":"77","author":"Sastre-Garau","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0610","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-012-2233-z","article-title":"Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer","volume":"136","author":"Lips","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.annpat.2026.01.006_bib0615","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1245\/s10434-018-6687-z","article-title":"Breast cancers of special histologic subtypes are biologically diverse","volume":"25","author":"Tadros","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0620","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/1078-0432.CCR-20-0260","article-title":"Prognostic value of EndoPredict in women with hormone receptor-positive, HER2-negative invasive lobular breast cancer","volume":"26","author":"Sestak","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0625","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41523-021-00366-x","article-title":"The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a national cancer database study","volume":"7","author":"Abel","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0630","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1245\/s10434-022-12065-3","article-title":"The 21-gene recurrence score in clinically high-risk lobular and ductal breast cancer: a national cancer database study","volume":"29","author":"Abel","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0635","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41523-019-0113-y","article-title":"LobSig is a multigene predictor of outcome in invasive lobular carcinoma","volume":"5","author":"McCart Reed","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0640","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.pas.0000213386.63160.3f","article-title":"Lobular versus ductal breast neoplasms: the diagnostic utility of p120\u00a0catenin","volume":"31","author":"Dabbs","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0645","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1172\/JCI41695","article-title":"Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance","volume":"121","author":"Schackmann","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annpat.2026.01.006_bib0650","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/path.6205","article-title":"Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type","volume":"261","author":"Sijnesael","year":"2023","journal-title":"J Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0655","first-page":"373","article-title":"Nuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through Kaiso-dependent Wnt11\u00a0expression","volume":"8","author":"van de Ven","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.annpat.2026.01.006_bib0660","doi-asserted-by":"crossref","first-page":"e37864","DOI":"10.1371\/journal.pone.0037864","article-title":"Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer","volume":"7","author":"Vermeulen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.annpat.2026.01.006_bib0665","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41388-022-02314-w","article-title":"Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer","volume":"41","author":"R\u00e4tze","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.annpat.2026.01.006_bib0670","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1038\/s41467-022-32523-6","article-title":"Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence","volume":"13","author":"Aouad","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.annpat.2026.01.006_bib0675","doi-asserted-by":"crossref","first-page":"15454","DOI":"10.1038\/s41598-018-33525-5","article-title":"E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer","volume":"8","author":"Teo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.annpat.2026.01.006_bib0680","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1158\/1078-0432.CCR-18-0279","article-title":"Loss of E-cadherin enhances IGF1-IGF1R pathway activation and sensitizes breast cancers to anti-IGF1R\/InsR inhibitors","volume":"24","author":"Nagle","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0685","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1158\/2159-8290.CD-17-0603","article-title":"E-Cadherin\/ROS1\u00a0inhibitor synthetic lethality in breast cancer","volume":"8","author":"Bajrami","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.annpat.2026.01.006_bib0690","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.3390\/cancers13215396","article-title":"Atlas of lobular breast cancer models: challenges and strategic directions","volume":"13","author":"Sflomos","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2026.01.006_bib0695","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1158\/0008-5472.CAN-21-3186","article-title":"A distinct chromatin state drives therapeutic resistance in invasive lobular breast cancer","volume":"82","author":"Nardone","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0700","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jnci\/djx268","article-title":"Immune infiltration in invasive lobular breast cancer","volume":"110","author":"Desmedt","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annpat.2026.01.006_bib0705","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/s41379-020-0561-9","article-title":"Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma","volume":"33","author":"Tille","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0710","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1158\/1078-0432.CCR-20-2268","article-title":"Characterization of stromal tumor-infiltrating lymphocytes and genomic alterations in metastatic lobular breast cancer","volume":"26","author":"Richard","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0715","series-title":"E-cadherin inactivation shapes tumor micro-environment specificities in ILC","author":"Djerroudi","year":"2024"},{"key":"10.1016\/j.annpat.2026.01.006_bib0720","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s43018-023-00527-w","article-title":"Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment","volume":"4","author":"Onkar","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0725","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1186\/s12885-020-07654-y","article-title":"Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis","volume":"20","author":"Gao","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0730","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jnci\/djx137","article-title":"Relevance of spatial heterogeneity of immune infiltration for predicting risk of recurrence after endocrine therapy of ER+ breast cancer","volume":"110","author":"Heindl","year":"2018","journal-title":"JNCI"},{"key":"10.1016\/j.annpat.2026.01.006_bib0735","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-023-02451-3","article-title":"Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence","author":"Makhlouf","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0740","doi-asserted-by":"crossref","first-page":"e153963","DOI":"10.1172\/jci.insight.153963","article-title":"Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer","volume":"7","author":"Egelston","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.annpat.2026.01.006_bib0745","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3390\/ijms19020611","article-title":"The role of the estrogen pathway in the tumor microenvironment","volume":"19","author":"Rothenberger","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.annpat.2026.01.006_bib0750","doi-asserted-by":"crossref","first-page":"15048","DOI":"10.3390\/ijms242015048","article-title":"Hormone receptor signaling and breast cancer resistance to anti-tumor immunity","volume":"24","author":"Moisand","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.annpat.2026.01.006_bib0755","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1158\/1078-0432.CCR-12-1000","article-title":"Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance","volume":"19","author":"Dunbier","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0760","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13058-020-01285-8","article-title":"Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial","volume":"22","author":"Skriver","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0765","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-015-3668-9","article-title":"Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets","volume":"155","author":"Nakagawa","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.annpat.2026.01.006_bib0770","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10549-016-3929-2","article-title":"Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma","volume":"159","author":"Park","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.annpat.2026.01.006_bib0775","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00428-020-02835-3","article-title":"Prognostic relevance of the loss of stromal CD34\u00a0positive fibroblasts in invasive lobular carcinoma of the breast","volume":"477","author":"Westhoff","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.annpat.2026.01.006_bib0780","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/cancers14040904","article-title":"Characterisation of the stromal microenvironment in lobular breast cancer","volume":"14","author":"G\u00f3mez-Cuadrado","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.annpat.2026.01.006_bib0785","doi-asserted-by":"crossref","first-page":"e13180","DOI":"10.15252\/emmm.202013180","article-title":"Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1","volume":"13","author":"Sflomos","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.annpat.2026.01.006_bib0790","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trecan.2020.03.001","article-title":"Drilling for oil: tumor-surrounding adipocytes fuelling cancer","volume":"6","author":"Attan\u00e9","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101283","article-title":"59P Tumor cells-adipocytes interactions are associated with poor disease outcome in invasive lobular carcinoma","volume":"8","author":"Serra","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.annpat.2026.01.006_bib0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-024-00627-5","article-title":"Reporting on invasive lobular breast cancer in clinical trials: a systematic review","volume":"10","author":"Van Baelen","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.annpat.2026.01.006_bib0805","article-title":"Clinical challenges and proposed solutions for patients with invasive lobular breast cancer","volume":"0","author":"Baelen","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annpat.2026.01.006_bib0810","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1158\/1078-0432.CCR-19-0713","article-title":"BET inhibition as a rational therapeutic strategy for invasive lobular breast cancer","volume":"25","author":"Walsh","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annpat.2026.01.006_bib0815","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/2767-9764.CRC-23-0044","article-title":"Proteogenomic approaches for the identification of NF1\/neurofibromin-depleted estrogen receptor-positive breast cancers for targeted treatment","volume":"3","author":"Kim","year":"2023","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.annpat.2026.01.006_bib0410","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s43018-023-00542-x","article-title":"PD-L1\u00a0blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial","volume":"4","author":"Voorwerk","year":"2023","journal-title":"Nat Cancer"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649826000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649826000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:02:25Z","timestamp":1783443745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649826000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0242649826000040"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2026.01.006","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les particularit\u00e9s cliniques, histopathologiques et biologiques des carcinomes lobulaires infiltrants","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}